These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


279 related items for PubMed ID: 5003602

  • 1. [Tuberculostatic test in the treatment of pulmonary tuberculosis with 1st and 2d class drugs].
    Gur'ian IE, Svitneva AS, Tarasova EF.
    Probl Tuberk; 1971; 49(12):33-6. PubMed ID: 5003602
    [No Abstract] [Full Text] [Related]

  • 2. [Comparison of drug resistance and blood bacteriostatic activity in patients with pulmonary tuberculosis].
    Kochetov BI, Gur'ian IE.
    Probl Tuberk; 1971; 49(6):64-7. PubMed ID: 5000745
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Methods of determining the bacteriostatic activity of the blood and the primary drug resistance of mycobacteria in pulmonary tuberculosis].
    Bibik NF.
    Probl Tuberk; 1980 Feb; (2):63-6. PubMed ID: 6769111
    [No Abstract] [Full Text] [Related]

  • 6. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P.
    Fortschr Med; 1983 Jun 16; 101(23):1075-80, 1090. PubMed ID: 6411560
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI, Terentieva AS.
    Probl Tuberk; 1981 Dec 16; (12):23-6. PubMed ID: 6801645
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical aspects of secondary resistance in pulmonary tuberculosis].
    Gugić B.
    Plucne Bolesti; 1985 Dec 16; 37(1-2):22-7. PubMed ID: 3934690
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis].
    Zozuliak VI.
    Vrach Delo; 1988 Jun 16; (6):54-5. PubMed ID: 3138824
    [No Abstract] [Full Text] [Related]

  • 12. [Bacterial excretion and the bacteriostatic activity of the blood in the chemotherapy of middle-aged and elderly tuberculosis patients].
    Ginzburg TS, Iakimets VP.
    Probl Tuberk; 1983 May 16; (5):57-61. PubMed ID: 6408638
    [No Abstract] [Full Text] [Related]

  • 13. [Psychosocial risk factors in pulmonary tuberculosis and the phenomenon of drug resistance in its treatment].
    Pecyna MB.
    Wiad Lek; 1988 Jan 01; 41(1):1-8. PubMed ID: 3136589
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J, Holecková R, Rozánek R, Starosta V, Strnad M, Sebests J, Strusa V.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965 Jan 01; 8(5):589-92. PubMed ID: 4955225
    [No Abstract] [Full Text] [Related]

  • 18. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated].
    Mordyński K, Piotrowski Z, Szymański A.
    Gruzlica; 1968 Aug 01; 36(8):715-8. PubMed ID: 4972465
    [No Abstract] [Full Text] [Related]

  • 19. [Specific serum antimycobacterial activity test in pulmonary tuberculosis patients].
    Yamagata Y, Konomata T.
    Iryo; 1966 May 01; 20(5):450-5. PubMed ID: 5963052
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG.
    Probl Tuberk; 1983 May 01; (5):38-42. PubMed ID: 6408637
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.